This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Morphosys Ag. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Daniel Weinfurtner: Innovator in Pharmaceutical Formulations
Introduction
Daniel Weinfurtner is a notable inventor based in Planegg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibody formulations. His work is characterized by a focus on innovative solutions that address critical medical needs.
Latest Patents
Daniel Weinfurtner holds a patent for an anti-CD19 antibody formulation. This pharmaceutical formulation is designed to enhance the efficacy of treatments targeting CD19, a protein commonly associated with certain types of cancer. His patent represents a crucial advancement in the development of targeted therapies.
Career Highlights
Weinfurtner is associated with MorphoSys AG, a leading biotechnology company specializing in the development of innovative therapies for cancer and autoimmune diseases. His role at MorphoSys AG has allowed him to contribute to groundbreaking research and development efforts in the pharmaceutical industry.
Collaborations
Throughout his career, Daniel has collaborated with esteemed colleagues, including Martin Hessling and Bodo Brocks. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Daniel Weinfurtner's contributions to pharmaceutical formulations, particularly in the area of anti-CD19 antibodies, highlight his role as a key innovator in the field. His work continues to influence the development of targeted therapies that can improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile